{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:16:10Z","timestamp":1794575770092,"version":"4.9.1"},"reference-count":66,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2019,9,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Migraine is a common neuroinflammatory disorder characterized by recurrent\nattacks of pain. Human and experimental models of migraine studies have demonstrated the role\nplayed by COX-2\/ iNOS in migraine\u2019s neuroinflammatory pathogenesis. COX-2 and iNOS are closely\nlinked and both contribute to inflammation and neurogenic pain in the central nervous system. Omega-\n3 fatty acids and curcumin, an active polyphenol of turmeric, have anti-inflammatory and neuroprotective\neffects through several mechanisms, including the suppression of COX-2 and iNOS gene expression,\nas well as their serum levels. The aim of the present study is to evaluate the nutrigenomic effects\nof \u03c9-3 fatty acids, nano-curcumin, and a combination of the two, on neuroinflammation and clinical\nsymptoms in migraine patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> This study reports the results of a clinical trial over a 2-month period, involving 74 episodic\nmigraine patients who received \u03c9-3 fatty acids, nano-curcumin, a combination of them, or a placebo.\nAt the start and end of the study, the expression of COX-2\/iNOS (in peripheral mononuclear blood\ncells isolated from patients) and COX-2\/iNOS serum levels were measured, using real-time PCR and\nELISA respectively. The frequency, severity and duration of pain attacks were also recorded.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The results of the present trial showed that \u03c9-3 fatty acids and nano-curcumin can reinforce\neach other\u2019s effects in the downregulation of COX-2\/iNOS mRNA, as well as reduce their serum levels.\nIn addition, the combination of \u03c9-3 and nano-curcumin significantly reduced the frequency, severity\nand duration of headaches (P&lt;0.05).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>These findings indicate that combination therapy of \u03c9-3 fatty acids and nano-curcumin\ncan be considered as a promising new approach in migraine prevention.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530319666190212170140","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T06:49:37Z","timestamp":1550126977000},"page":"874-884","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["The Neuromodulatory Effects of \u03c9-3 Fatty Acids and Nano-Curcumin on the COX-2\/ iNOS Network in Migraines: A Clinical Trial Study from Gene Expression to Clinical Symptoms"],"prefix":"10.2174","volume":"19","author":[{"given":"Mina","family":"Abdolahi","sequence":"first","affiliation":[{"name":"AmirAlam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Jafarieh","sequence":"additional","affiliation":[{"name":"AmirAlam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Sarraf","sequence":"additional","affiliation":[{"name":"Iranian Centre of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Sedighiyan","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolghasem","family":"Yousefi","sequence":"additional","affiliation":[{"name":"AmirAlam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Tafakhori","sequence":"additional","affiliation":[{"name":"Iranian Centre of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Abdollahi","sequence":"additional","affiliation":[{"name":"AmirAlam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farahnaz","family":"Salehinia","sequence":"additional","affiliation":[{"name":"AmirAlam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Djalali","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/head.12074","volume":"53","author":"Smitherman T.A.","year":"2013","unstructured":"Smitherman T.A.; Burch R.; Sheikh H.; Loder E.; The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache 2013,53(3),427-436","journal-title":"Headache"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1093\/hmg\/ddt364","volume":"22","author":"Zameel Cader M.","year":"2013","unstructured":"Zameel Cader M.; The molecular pathogenesis of migraine: new developments and opportunities. Hum Mol Genet 2013,22(R1),R39-R44","journal-title":"Hum Mol Genet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4103\/0972-2327.182302","volume":"19","author":"Malhotra R.","year":"2016","unstructured":"Malhotra R.; Understanding migraine: Potential role of neurogenic inflammation. Ann Indian Acad Neurol 2016,19(2),175-182","journal-title":"Ann Indian Acad Neurol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1159\/000082180","volume":"4","author":"Liddle R.A.","year":"2004","unstructured":"Liddle R.A.; Nathan J.D.; Neurogenic inflammation and pancreatitis. Pancreatology 2004,4(6),551-559","journal-title":"Pancreatology"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1517\/13543784.2014.918953","volume":"23","author":"Barbanti P.","year":"2014","unstructured":"Barbanti P.; Egeo G.; Aurilia C.; Fofi L.; Della-Morte D.; Drugs targeting nitric oxide synthase for migraine treatment. Expert Opin Investig Drugs 2014,23(8),1141-1148","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/0333102413502735","volume":"34","author":"Ramachandran R.","year":"2014","unstructured":"Ramachandran R.; Bhatt D.K.; Ploug K.B.; Hay-Schmidt A.; Jansen-Olesen I.; Gupta S.; Olesen J.; Nitric oxide synthase, calcitonin gene-related peptide and NK-1 receptor mechanisms are involved in GTN-induced neuronal activation. Cephalalgia 2014,34(2),136-147","journal-title":"Cephalalgia"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1248\/bpb.34.1170","volume":"34","author":"Kawabata A.","year":"2011","unstructured":"Kawabata A.; Prostaglandin E2 and pain--an update. Biol Pharm Bull 2011,34(8),1170-1173","journal-title":"Biol Pharm Bull"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0074-7742(07)82020-4","volume":"82","author":"Tassorelli C.","year":"2007","unstructured":"Tassorelli C.; Greco R.; Armentero M.T.; Blandini F.; Sandrini G.; Nappi G.; A role for brain cyclooxygenase-2 and prostaglandin-E2 in migraine: effects of nitroglycerin. Int Rev Neurobiol 2007,82,373-382","journal-title":"Int Rev Neurobiol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1046\/j.1468-2982.2000.00025.x","volume":"20","author":"Stirparo G.","year":"2000","unstructured":"Stirparo G.; Zicari A.; Favilla M.; Lipari M.; Martelletti P.; Linked activation of nitric oxide synthase and cyclooxygenase in peripheral monocytes of asymptomatic migraine without aura patients. Cephalalgia 2000,20(2),100-106","journal-title":"Cephalalgia"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1526-4610.2006.00721.x","volume":"47","author":"Varga H.","year":"2007","unstructured":"Varga H.; Pardutz A.; Vamos E.; Plangar I.; Egyud E.; Tajti J.; Bari F.; Vecsei L.; Cox-2 inhibitor attenuates NO-induced nNOS in rat caudal trigeminal nucleus. Headache 2007,47(9),1319-1325","journal-title":"Headache"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3892\/mmr.2015.3616","volume":"12","author":"Dong X.","year":"2015","unstructured":"Dong X.; Hu Y.; Jing L.; Chen J.; Role of phosphorylated extracellular signal-regulated kinase, calcitonin gene-related peptide and cyclooxygenase-2 in experimental rat models of migraine. Mol Med Rep 2015,12(2),1803-1809","journal-title":"Mol Med Rep"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11940-011-0155-4","volume":"14","author":"Hoffmann J.","year":"2012","unstructured":"Hoffmann J.; Goadsby P.J.; New agents for acute treatment of migraine: CGRP receptor antagonists, iNOS inhibitors. Curr Treat Options Neurol 2012,14(1),50-59","journal-title":"Curr Treat Options Neurol"},{"key":"ref=13","volume":"2","author":"Sedighiyan M.","year":"2016","unstructured":"Sedighiyan M.; Abdolahi M.; Honarvar N.M.; Hosseini B.; Djafarian K.; Curcumin a novel agent targeting inflammatory pathways in obesity. J Nutr Sci Diet 2016,2(5)","journal-title":"J Nutr Sci Diet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.nutr.012809.104635","volume":"31","author":"Bazan N.G.","year":"2011","unstructured":"Bazan N.G.; Molina M.F.; Gordon W.C.; Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer\u2019s, and other neurodegenerative diseases. Annu Rev Nutr 2011,31,321-351","journal-title":"Annu Rev Nutr"},{"key":"ref=15","author":"Hatami M.","year":"2018","unstructured":"Hatami M.; Abdolahi M.; Soveyd N.; Djalali M.; Togha M.; Honarvar N.; Molecular Mechanisms of Curcumin in Neuroinflammatory Disorders: A Mini Review of Current Evidences. Endocr Metab Immune Disord Drug Targets 2018","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1017\/S0007114511000390","volume":"106","author":"Jia Q.","year":"2011","unstructured":"Jia Q.; Ivanov I.; Zlatev Z.Z.; Alaniz R.C.; Weeks B.R.; Callaway E.S.; Goldsby J.S.; Davidson L.A.; Fan Y-Y.; Zhou L.; Lupton J.R.; McMurray D.N.; Chapkin R.S.; Dietary fish oil and curcumin combine to modulate colonic cytokinetics and gene expression in dextran sodium sulphate-treated mice. Br J Nutr 2011,106(4),519-529","journal-title":"Br J Nutr"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.plefa.2010.02.006","volume":"82","author":"Lay\u00e9 S.","year":"2010","unstructured":"Lay\u00e9 S.; Polyunsaturated fatty acids, neuroinflammation and well being. Prostaglandins Leukot Essent Fatty Acids 2010,82(4-6),295-303","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref=18","first-page":"210","volume":"16","author":"Soveyd N.","year":"2017","unstructured":"Soveyd N.; Abdolahi M.; Bitarafan S.; Tafakhori A.; Sarraf P.; Togha M.; Okhovat A.A.; Hatami M.; Sedighiyan M.; Djalali M.; Mohammadzadeh Honarvar N.; Molecular mechanisms of omega-3 fatty acids in the migraine headache. Iran J Neurol 2017,16(4),210-217","journal-title":"Iran J Neurol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1358\/dof.2010.035.02.1426640","volume":"35","author":"Shehzad A.","year":"2010","unstructured":"Shehzad A.; Lee Y.; Curcumin: Multiple molecular targets mediate multiple pharmacological actions: A review. Drugs Future 2010,35(2),113","journal-title":"Drugs Future"},{"key":"ref=20","author":"Kunnumakkara A.B.","year":"2016","unstructured":"Kunnumakkara A.B.; Bordoloi D.; Padmavathi G.; Monisha J.; Roy N.K.; Prasad S.; Aggarwal B.B.; Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol 2016","journal-title":"Br J Pharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","volume":"75","author":"Goel A.","year":"2008","unstructured":"Goel A.; Kunnumakkara A.B.; Aggarwal B.B.; Curcumin as \u201cCurecumin\u201d: from kitchen to clinic. Biochem Pharmacol 2008,75(4),787-809","journal-title":"Biochem Pharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/biof.1041","volume":"39","author":"Shishodia S.","year":"2013","unstructured":"Shishodia S.; Molecular mechanisms of curcumin action: gene expression. Biofactors 2013,39(1),37-55","journal-title":"Biofactors"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00280-011-1673-1","volume":"69","author":"Kanai M.","year":"2012","unstructured":"Kanai M.; Imaizumi A.; Otsuka Y.; Sasaki H.; Hashiguchi M.; Tsujiko K.; Matsumoto S.; Ishiguro H.; Chiba T.; Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother Pharmacol 2012,69(1),65-70","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1248\/bpb.34.660","volume":"34","author":"Sasaki H.","year":"2011","unstructured":"Sasaki H.; Sunagawa Y.; Takahashi K.; Imaizumi A.; Fukuda H.; Hashimoto T.; Wada H.; Katanasaka Y.; Kakeya H.; Fujita M.; Hasegawa K.; Morimoto T.; Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull 2011,34(5),660-665","journal-title":"Biol Pharm Bull"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ptr.2662","volume":"23","author":"Mittal N.","year":"2009","unstructured":"Mittal N.; Joshi R.; Hota D.; Chakrabarti A.; Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat. Phytother Res 2009,23(4),507-512","journal-title":"Phytother Res"},{"key":"ref=26","first-page":"21","volume":"11","author":"Tajmirriahi M.","year":"2012","unstructured":"Tajmirriahi M.; Sohelipour M.; Basiri K.; Shaygannejad V.; Ghorbani A.; Saadatnia M.; The effects of sodium valproate with fish oil supplementation or alone in migraine prevention: A randomized single-blind clinical trial. Iran J Neurol 2012,11(1),21-24","journal-title":"Iran J Neurol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuint.2016.02.014","volume":"95","author":"Lei E.","year":"2016","unstructured":"Lei E.; Vacy K.; Boon W.C.; Fatty acids and their therapeutic potential in neurological disorders. Neurochem Int 2016,95,75-84","journal-title":"Neurochem Int"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","volume":"41","author":"Lipton R.B.","year":"2001","unstructured":"Lipton R.B.; Stewart W.F.; Diamond S.; Diamond M.L.; Reed M.; Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001,41(7),646-657","journal-title":"Headache"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.2174\/1871527317666171213154749","volume":"16","author":"Soveyd N.","year":"2018","unstructured":"Soveyd N.; Abdolahi M.; Djalali M.; Hatami M.; Tafakhori A.; Sarraf P.; Honarvar N.M.; The combined effects of \u03c9-3 fatty acids and nano-curcumin supplementation on intercellular adhesion molecule-1 (ICAM-1) gene expression and serum levels in migraine patients. CNS Neurol Disord Drug Targets 2018,16(10),1120-1126","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"430","DOI":"10.2174\/1871527317666180625101643","volume":"17","author":"Abdolahi M.","year":"2018","unstructured":"Abdolahi M.; Sarraf P.; Javanbakht M.H.; Honarvar N.M.; Hatami M.; Soveyd N.; Tafakhori A.; Sedighiyan M.; Djalali M.; Jafarieh A.; Masoudian Y.; Djalali M.; A Novel Combination of \u03c9-3 Fatty Acids and Nano-Curcumin Modulates Interleukin-6 Gene Expression and High Sensitivity C-reactive Protein Serum Levels in Patients with Migraine: A Randomized Clinical Trial Study. CNS Neurol Disord Drug Targets 2018,17(6),430-438","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=31","first-page":"42","volume":"5","author":"Abdolahi M.","year":"2016","unstructured":"Abdolahi M.; Mohammadzadeh Honarvar N.; Tafakhori A.; Sarraf P.; Hatami M.; Soveyd N.; The combined effects of omega3 fatty acids and nanocurcumin supplementation on gene expression and serum levels of some inflammatory and endothelial factors in migraine patients: Study protocol for a randomized controlled trial. Int J. Pharm Sci Invent 2016,5(3),42-46","journal-title":"Pharm Sci Invent"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00251-017-0992-8","volume":"69","author":"Abdolahi M.","year":"2017","unstructured":"Abdolahi M.; Tafakhori A.; Togha M.; Okhovat A.A.; Siassi F.; Eshraghian M.R.; Sedighiyan M.; Djalali M.; Mohammadzadeh Honarvar N.; Djalali M.; The synergistic effects of \u03c9-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-\u03b1 gene expression and serum level in migraine patients. Immunogenetics 2017,69(6),371-378","journal-title":"Immunogenetics"},{"key":"ref=33","author":"Gerring Z.F.","unstructured":"Gerring Z.F.; Powell J.E.; Montgomery G.W.; Nyholt D.R.;  Genome-wide analysis of blood gene expression in migraine implicates immune-inflammatory pathways Cephalalgia, 20170333102416686769","journal-title":"Genome-wide analysis of blood gene expression in migraine implicates immune-inflammatory pathways Cephalalgia, 20170333102416686769"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1073\/pnas.032670899","volume":"99","author":"Koistinaho M.","year":"2002","unstructured":"Koistinaho M.; Kettunen M.I.; Goldsteins G.; Kein\u00e4nen R.; Salminen A.; Ort M.; Bures J.; Liu D.; Kauppinen R.A.; Higgins L.S.; Koistinaho J.; \u03b2-amyloid precursor protein transgenic mice that harbor diffuse A \u03b2 deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. Proc Natl Acad Sci USA 2002,99(3),1610-1615","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/484613","author":"Hsieh H.-L.","unstructured":"Hsieh H.-L.; Yang C.-M.;  Role of redox signaling in neuroinflammation and neurodegenerative diseases BioMed Res Int 2013, 2013","journal-title":"Role of redox signaling in neuroinflammation and neurodegenerative diseases BioMed Res Int 2013, 2013"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1006\/exnr.1997.6429","volume":"144","author":"Tocco G.","year":"1997","unstructured":"Tocco G.; Freire-Moar J.; Schreiber S.S.; Sakhi S.H.; Aisen P.S.; Pasinetti G.M.; Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer\u2019s disease. Exp Neurol 1997,144(2),339-349","journal-title":"Exp Neurol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1002\/jcp.22560","volume":"226","author":"Wang H.H.","year":"2011","unstructured":"Wang H.H.; Hsieh H.L.; Yang C.M.; Nitric oxide production by endothelin-1 enhances astrocytic migration via the tyrosine nitration of matrix metalloproteinase-9. J Cell Physiol 2011,226(9),2244-2256","journal-title":"J Cell Physiol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/omi.2010.0095","volume":"15","author":"Giacalone A.","year":"2011","unstructured":"Giacalone A.; Montalto G.; Giannitrapani L.; Balasus D.; Terranova A.; Cervello M.; Soresi M.; Maras\u00e0 L.; Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-\u03b1, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma. OMICS 2011,15(3),193-196","journal-title":"OMICS"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11010-012-1409-5","volume":"370","author":"Gon\u00e7alves F.M.","year":"2012","unstructured":"Gon\u00e7alves F.M.; Luizon M.R.; Speciali J.G.; Martins-Oliveira A.; Dach F.; Tanus-Santos J.E.; Interaction among nitric oxide (NO)-related genes in migraine susceptibility. Mol Cell Biochem 2012,370(1-2),183-189","journal-title":"Mol Cell Biochem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/j.yexcr.2012.05.027","volume":"318","author":"Zhu Y.","year":"2012","unstructured":"Zhu Y.; Zhu M.; Lance P.; iNOS signaling interacts with COX-2 pathway in colonic fibroblasts. Exp Cell Res 2012,318(16),2116-2127","journal-title":"Exp Cell Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1159\/000235898","volume":"18","author":"Franco L.","year":"2009","unstructured":"Franco L.; Talamini G.; Cross-talk between inducible nitric oxide synthase and cyclooxygenase in Helicobacter-pylori-induced gastritis. Med Princ Pract 2009,18(6),477-481","journal-title":"Med Princ Pract"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1046\/j.1468-2982.2000.00146.x","volume":"20","author":"Sarchielli P.","year":"2000","unstructured":"Sarchielli P.; Alberti A.; Codini M.; Floridi A.; Gallai V.; Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 2000,20(10),907-918","journal-title":"Cephalalgia"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1126\/science.1119407","volume":"310","author":"Kim S.F.","year":"2005","unstructured":"Kim S.F.; Huri D.A.; Snyder S.H.; Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 2005,310(5756),1966-1970","journal-title":"Science"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"s51","DOI":"10.1007\/s101940170010","volume":"2","author":"Martelletti P.","year":"2001","unstructured":"Martelletti P.; Zicari A.; Realacci M.; Fiore G.; De Filippis S.; Stirparo G.; Denora P.; Solimeo M.D.; Rinaldi C.; Morrone S.; Expression of NOS-2, COX-2 and Th1\/Th2 cytokines in migraine. J Headache Pain 2001,2(1),s51-s56","journal-title":"J Headache Pain"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","volume":"15","author":"Gupta S.C.","year":"2013","unstructured":"Gupta S.C.; Patchva S.; Aggarwal B.B.; Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 2013,15(1),195-218","journal-title":"AAPS J"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bcp.2009.08.030","volume":"79","author":"Saw C.L.L.","year":"2010","unstructured":"Saw C.L.L.; Huang Y.; Kong A-N.; Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: docosahexaenoic acid or eicosapentaenoic acid. Biochem Pharmacol 2010,79(3),421-430","journal-title":"Biochem Pharmacol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1186\/s13063-016-1702-9","volume":"17","author":"Thota R.N.","year":"2016","unstructured":"Thota R.N.; Acharya S.H.; Abbott K.A.; Garg M.L.; Curcumin and long-chain Omega-3 polyunsaturated fatty acids for Prevention of type 2 Diabetes (COP-D): study protocol for a randomised controlled trial. Trials 2016,17(1),565","journal-title":"Trials"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s11095-013-1252-8","volume":"31","author":"Shah L.","year":"2014","unstructured":"Shah L.; Gattacceca F.; Amiji M.M.; CNS delivery and pharmacokinetic evaluations of DALDA analgesic peptide analog administered in Nano-sized oil-in-water emulsion formulation. Pharm Res 2014,31(5),1315-1324","journal-title":"Pharm Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3389\/fncel.2014.00337","volume":"8","author":"Zaky A.","year":"2014","unstructured":"Zaky A.; Mahmoud M.; Awad D.; El Sabaa B.M.; Kandeel K.M.; Bassiouny A.R.; Valproic acid potentiates curcumin-mediated neuroprotection in lipopolysaccharide induced rats. Front Cell Neurosci 2014,8,337","journal-title":"Front Cell Neurosci"},{"key":"ref=50","author":"Zaky A.","year":"2017","unstructured":"Zaky A.; Bassiouny A.; Farghaly M.; El-Sabaa B. M.;  A Combination of Resveratrol and Curcumin is Effective Against Aluminum Chloride-Induced Neuroinflammation in Rats J Alzheimers Dis (Preprint) 1-152017","journal-title":"A Combination of Resveratrol and Curcumin is Effective Against Aluminum Chloride-Induced Neuroinflammation in Rats J Alzheimers Dis"},{"key":"ref=51","author":"Ramirez-Ramirez V.","unstructured":"Ramirez-Ramirez V.; Macias-Islas M.; Ortiz G. G.; Pacheco-Moises F.; Torres-Sanchez E.; Sorto-Gomez T.; Cruz-Ramos J.; Orozco-Avi\u00f1a G.; Celis De La Rosa A.; Efficacy of fish oil on serum of TNF\u03b1, IL-1\u03b2, and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b Oxid Med. Cell Longev., 2013, 2013"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1038\/npp.2010.98","volume":"35","author":"Lu D-Y.","year":"2010","unstructured":"Lu D-Y.; Tsao Y-Y.; Leung Y-M.; Su K-P.; Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for \u03c9-3 fatty acids. Neuropsychopharmacology 2010,35(11),2238-2248","journal-title":"Neuropsychopharmacology"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.intimp.2006.10.001","volume":"7","author":"Moon D-O.","year":"2007","unstructured":"Moon D-O.; Kim K-C.; Jin C-Y.; Han M-H.; Park C.; Lee K-J.; Park Y-M.; Choi Y.H.; Kim G-Y.; Inhibitory effects of eicosapentaenoic acid on lipopolysaccharide-induced activation in BV2 microglia. Int Immunopharmacol 2007,7(2),222-229","journal-title":"Int Immunopharmacol"},{"key":"ref=54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015816","volume":"6","author":"Zhao Y.","year":"2011","unstructured":"Zhao Y.; Calon F.; Julien C.; Winkler J.W.; Petasis N.A.; Lukiw W.J.; Bazan N.G.; Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPAR\u03b3-mediated mechanisms in Alzheimer\u2019s disease models. PLoS One 2011,6(1)","journal-title":"PLoS One"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11011-013-9416-0","volume":"28","author":"Ortiz G.G.","year":"2013","unstructured":"Ortiz G.G.; Pacheco-Mois\u00e9s F.P.; G\u00f3mez-Rodr\u00edguez V.M.; Gonz\u00e1lez-Renovato E.D.; Torres-S\u00e1nchez E.D.; Ram\u00edrez-Anguiano A.C.; Fish oil, melatonin and vitamin E attenuates midbrain cyclooxygenase-2 activity and oxidative stress after the administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Metab Brain Dis 2013,28(4),705-709","journal-title":"Metab Brain Dis"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S1054-139X(02)00349-X","volume":"31","author":"Harel Z.","year":"2002","unstructured":"Harel Z.; Gascon G.; Riggs S.; Vaz R.; Brown W.; Exil G.; Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. J Adolesc Health 2002,31(2),154-161","journal-title":"J Adolesc Health"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1046\/j.1468-2982.2001.218240.x","volume":"21","author":"Pradalier A.","year":"2001","unstructured":"Pradalier A.; Bakouche P.; Baudesson G.; Delage A.; Cornaille-Lafage G.; Launay J.M.; Biason P.; Failure of omega-3 polyunsaturated fatty acids in prevention of migraine: A double-blind study versus placebo. Cephalalgia 2001,21(8),818-822","journal-title":"Cephalalgia"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1373\/clinchem.2012.190199","volume":"58","author":"Mas E.","year":"2012","unstructured":"Mas E.; Croft K.D.; Zahra P.; Barden A.; Mori T.A.; Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin Chem 2012,58(10),1476-1484","journal-title":"Clin Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","volume":"21","author":"Simopoulos A.P.","year":"2002","unstructured":"Simopoulos A.P.; Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002,21(6),495-505","journal-title":"J Am Coll Nutr"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"279","DOI":"10.22203\/eCM.v033a21","volume":"33","author":"Xiao L.","year":"2017","unstructured":"Xiao L.; Ding M.; Fernandez A.; Zhao P.; Jin L.; Li X.; Curcumin alleviates lumbar radiculopathy by reducing neuroinflammation, oxidative stress and nociceptive factors. Eur Cell Mater 2017,33,279-293","journal-title":"Eur Cell Mater"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/bja\/aet176","volume":"111","author":"Lee J.Y.","year":"2013","unstructured":"Lee J.Y.; Shin T.J.; Choi J.M.; Seo K.S.; Kim H.J.; Yoon T.G.; Lee Y.S.; Han H.; Chung H.J.; Oh Y.; Jung S.J.; Shin K.J.; Antinociceptive curcuminoid, KMS4034, effects on inflammatory and neuropathic pain likely via modulating TRPV1 in mice. Br J Anaesth 2013,111(4),667-672","journal-title":"Br J Anaesth"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2174\/1574884711666160603012237","volume":"11","author":"Bulaj G.","year":"2016","unstructured":"Bulaj G.; Ahern M.M.; Kuhn A.; Judkins Z.S.; Bowen R.C.; Chen Y.; Incorporating natural products, pharmaceutical drugs, self-care and digital\/mobile health technologies into molecular-behavioral combination therapies for chronic diseases. Curr Clin Pharmacol 2016,11(2),128-145","journal-title":"Curr Clin Pharmacol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.molbrainres.2004.12.003","volume":"135","author":"T\u00f3th A.","year":"2005","unstructured":"T\u00f3th A.; Bocz\u00e1n J.; Kedei N.; Lizanecz E.; Bagi Z.; Papp Z.; \u00c9des I.; Csiba L.; Blumberg P.M.; Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res Mol Brain Res 2005,135(1-2),162-168","journal-title":"Brain Res Mol Brain Res"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1369\/0022155413513589","volume":"62","author":"T\u00f3th A.","year":"2014","unstructured":"T\u00f3th A.; Czikora A.; P\u00e1sztor E.T.; Dienes B.; Bai P.; Csernoch L.; Rutkai I.; Csat\u00f3 V.; M\u00e1nyin\u00e9 I.S.; P\u00f3rsz\u00e1sz R.; Edes I.; Papp Z.; Bocz\u00e1n J.; Vanilloid receptor-1 (TRPV1) expression and function in the vasculature of the rat. J Histochem Cytochem 2014,62(2),129-144","journal-title":"J Histochem Cytochem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"FF05","DOI":"10.7860\/JCDR\/2017\/25036.9596","volume":"11","author":"Kunder S.K.","year":"2017","unstructured":"Kunder S.K.; Bairy L.K.; Arivazhahan A.; Effect of Sodium Valproate and Docosahexaenoic Acid on Pain in Rats. J Clin Diagn Res 2017,11(3),FF05-FF08","journal-title":"J Clin Diagn Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1021\/la304642m","volume":"29","author":"Zhang J.","year":"2013","unstructured":"Zhang J.; Li L.; Wang J.; Xu J.; Sun D.; Phase inversion of emulsions containing a lipophilic surfactant induced by clay concentration. Langmuir 2013,29(12),3889-3894","journal-title":"Langmuir"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T05:22:28Z","timestamp":1574486548000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169937\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,9,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530319666190212170140","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-09-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}